Suppr超能文献

维生素 D 结合蛋白总量、“非生物利用型”、生物利用型和游离 25-羟维生素 D 与老年人群大型基于人群队列的死亡率。

Vitamin D-binding protein, total, "nonbioavailable," bioavailable, and free 25-hydroxyvitamin D, and mortality in a large population-based cohort of older adults.

机构信息

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.

出版信息

J Intern Med. 2022 Sep;292(3):463-476. doi: 10.1111/joim.13494. Epub 2022 Apr 13.

Abstract

BACKGROUND

Epidemiological studies consistently find low concentrations of 25-hydroxyvitamin D (25(OH)D) in blood to be associated with increased mortality, and a recent large-scale Mendelian randomization study strongly supports a causal relationship among individuals with low vitamin D status. Evolving evidence suggested that bioavailable or free 25(OH)D may better predict mortality. We aimed to compare the prognostic values of vitamin D-binding protein (VDBP), total, bioavailable, complementary "nonbioavailable", and free 25(OH)D for total and cause-specific mortality in a large population-based cohort study of older adults from Germany.

METHODS

Bioavailable, complementary "nonbioavailable", and free 25(OH)D concentrations were calculated among 5899 participants aged 50-75 years, based on serum concentrations of total 25(OH)D, VDBP, and albumin. The cohort was followed with respect to total and cause-specific mortality from recruitment in 2001-2002 up to the end of 2018. Multivariable Cox proportional hazards regression models were used to assess the associations between various vitamin D biomarkers and mortality, and further stratified by vitamin D status.

RESULTS

During a median follow-up of 17.1 years, 1739 participants died, of whom 575, 584, and 94 died of cardiovascular diseases, cancer, and respiratory diseases, respectively. Very similar inverse associations with total mortality (hazard ratio (HR) per standard deviation decrease: 1.17, 95% confidence interval (CI): 1.11, 1.24 for total 25(OH)D; HR: 1.14, 95% CI: 1.08, 1.21 for bioavailable 25(OH)D; HR: 1.12, 95% CI: 1.06, 1.18 for free 25(OH)D) and cause-specific mortalities were seen for all biomarkers of vitamin D status. The strongest associations were consistently seen for respiratory mortality. These inverse associations were strongest among participants with low vitamin D levels (<50 nmol/L). No significant associations were seen between VDBP and mortality.

CONCLUSIONS

Total, nonbioavailable, bioavailable, and free 25(OH)D showed very similar inverse associations with total and cause-specific mortality, which were strongest among those with low vitamin D status in this large population-based cohort.

摘要

背景

流行病学研究一致发现,血液中 25-羟维生素 D(25(OH)D)浓度较低与死亡率增加有关,最近一项大规模的孟德尔随机化研究强烈支持维生素 D 状态较低的个体之间存在因果关系。不断发展的证据表明,生物可利用或游离 25(OH)D 可能更好地预测死亡率。我们旨在比较维生素 D 结合蛋白(VDBP)、总、生物可利用、互补“非生物利用”和游离 25(OH)D 在德国一项大型基于人群的老年人群队列研究中对总死亡率和特定原因死亡率的预后价值。

方法

在 5899 名年龄在 50-75 岁的参与者中,根据血清总 25(OH)D、VDBP 和白蛋白的浓度计算了生物可利用、互补“非生物利用”和游离 25(OH)D 浓度。从 2001-2002 年招募开始,对该队列进行了总死亡率和特定原因死亡率的随访,直到 2018 年底。多变量 Cox 比例风险回归模型用于评估各种维生素 D 生物标志物与死亡率之间的关系,并按维生素 D 状态进一步分层。

结果

在中位随访 17.1 年期间,有 1739 名参与者死亡,其中 575、584 和 94 人分别死于心血管疾病、癌症和呼吸系统疾病。与总死亡率呈非常相似的反比关系(每标准偏差降低的危险比:总 25(OH)D 为 1.17,95%置信区间(CI)为 1.11,1.24;生物可利用 25(OH)D 为 1.14,95%CI:1.08,1.21;游离 25(OH)D 为 1.12,95%CI:1.06,1.18)和特定原因死亡率,所有维生素 D 状态的生物标志物均可见。与呼吸系统死亡率的关联最强。这些反比关联在维生素 D 水平较低(<50nmol/L)的参与者中最为明显。VDBP 与死亡率之间无显著关联。

结论

总、非生物利用、生物利用和游离 25(OH)D 与总死亡率和特定原因死亡率呈非常相似的反比关系,在该大型基于人群的队列中,维生素 D 状态较低的参与者中这种关系最强。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验